1 Jun 2024Open access
Cell Free DNA in SLE Patients: A Possible Marker of Disease Activity and Organ DamagePublisher siteQJM, Chronic Myeloid Leukemia Treatments
Active, last published 2026
In systemic lupus erythematosus research
Neama
Lotfy
Scholar“Research focused on Systemic Lupus Erythematosus Research and adjacent fields.”
Claim Your Profile4
H-index
63
Citations
Neama has not officially claimed their profile. If you are Neama, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
eama Lotfy is a researcher working on Systemic Lupus Erythematosus Research. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Neama's work has been cited 63 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Systemic Lupus Erythematosus Research×7Hepatitis C virus research×3Liver Disease Diagnosis and Treatment×3Renal Transplantation Outcomes and Treatments×3Pharmacogenetics and Drug Metabolism×3
04 · Where I am
Affiliations
Affiliation on published researchBadr University in Cairo, EgyptDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
2 works4 Dec 20231cites
Effect of CYP3A4*22, CYP3A5*3 and POR*28 genetic polymorphisms on calcineurin inhibitors dose requirements in early phase renal transplant patientsPublisher sitePharmacogenetics and Genomics, Renal Transplantation Outcomes and Treatments
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Neama?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you